Canonical Pathways | Spruce | Pine | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
[−log(p-value)] | A549 | RAW264.7 | BALF | A549 | RAW264.7 | BALF | ||||
 | Normal | Enhanced | Normal | Enhanced |  | Normal | Enhanced | Normal | Enhanced |  |
Glucocorticoid receptor signaling | 1.28 | 1.60 | 0.58 | 1.13 | 2.19 | 2.42 | 2.31 | 2.12 | 2.37 | 2.79 |
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 1.85 | 1.85 | 0.31 | 2.79 | 1.04 | 1.62 | 2.60 | 1.81 | 4.62 | – |
NRF2-mediated Oxidative Stress Response | 1.49 | 1.90 | 1.82 | 1.26 | 1.55 | 2.23 | 1.54 | 3.57 | 2.19 | 0.62 |
TNFR2 Signaling | 1.55 | 0.98 | 1.19 | 4.64 | 0.30 | 1.54 | 1.08 | 1.75 | 3.83 | 1.00 |
Aryl Hydrocarbon Receptor Signaling | 1.03 | 1.82 | 1.45 | 2.23 | 1.10 | 3.13 | 3.21 | 0.85 | 2.30 | 0.69 |
IL-17A Signaling in Fibroblast | 1.20 | 1.52 | 2.30 | 3.57 | 0.28 | 1.19 | 1.68 | 1.64 | 3.62 | 0.36 |
Role of PKR in Interferon Induction and Antiviral Response | 2.84 | 3.22 | – | 2.24 | – | 2.82 | 2.30 | – | 2.92 | – |
IL-17A Signaling in Gastric Cells | 0.84 | 1.20 | 3.20 | 3.90 | 0.40 | 0.83 | 1.32 | 0.99 | 2.25 | 1.24 |
p38 MAPK Signaling | 2.04 | 1.77 | 0.96 | 1.39 | 0.61 | 3.10 | 2.42 | 1.23 | 1.79 | 0.23 |
p53 Signaling | 1.15 | 1.49 | 2.08 | 2.64 | 1.01 | 1.70 | 1.45 | 1.65 | 1.55 | 0.24 |
GADD45 Signaling | 0.70 | 1.10 | 2.66 | 3.39 | Â | 1.18 | 1.20 | 1.83 | 2.54 | 0.54 |
Il-6 Signaling | 0.68 | 1.11 | 1.15 | 2.63 | 0.74 | 1.06 | 0.89 | 2.50 | 3.59 | 0.38 |
Aldosterone Signaling in Epithelial Cells | 1.03 | 1.96 | 0.50 | 1.44 | 1.09 | 2.90 | 2.66 | 1.66 | 0.57 | 0.78 |
IL-10 Signaling | 0.95 | 0.83 | 1.73 | 1.55 | 0.35 | 1.25 | 0.97 | 2.71 | 3.70 | 0.48 |
Unfolded Protein Response | 1.47 | 1.70 | 1.68 | 1.51 | 0.88 | 1.45 | 1.91 | 1.20 | 2.03 | 0.20 |
PPAR Signaling | 1.24 | 1.63 | 0.92 | 1.38 | 0.42 | 1.84 | 1.56 | 2.38 | 2.21 | 0.29 |